Jonathan W. Friedberg, M.D., M.M.Sc.

Jonathan W. Friedberg, M.D., M.M.Sc.

Contact Information

University of Rochester Medical Center
School of Medicine and Dentistry
601 Elmwood Ave, Box 704
Rochester, NY 14642

Administrative: (585) 275-4911
Fax: (585) 273-5761
Office: (585) 275-5823

Professional Bio

Jonathan W. Friedberg, M.D., is Director of the James P. Wilmot Cancer Institute, and Director of Hematological Malignancies Clinical Research.

He is a driving force behind the operations of our clinical programs and a key member of the center's lymphoma Specialized Program of Research Excellence, funded by the National Cancer Institute.

Friedberg is a member of the lymphoma committee in the Southwest Oncology Group, and serves as principal investigator on many local and national lymphoma treatment protocols for both Hodgkin lymphoma and non-Hodgkin's lymphoma.

Dr. Friedberg received his medical degree from Harvard Medical School. His postgraduate training included an internship and residency at Massachusetts General Hospital. He also completed a medical oncology and hematology fellowship at Dana-Farber/Partners Cancer Care in Boston. Dr. Friedberg also has an M.M.Sc. degree from Harvard Medical School in clinical investigation. He holds subspecialty certification in Medical Oncology and Hematology.

His research interests focus on development of novel therapies for patients with lymphoma. Most recently, he was awarded the Scholar in Clinical Research award from the Leukemia & Lymphoma Society, based upon his work with an oral inhibitor of a protein called Syk, which demonstrated efficacy in the treatment of several different forms of lymphoma, and was selected as a plenary presentation at the annual meeting of the American Society of Hematology.

Awards & Honors (National)

Lawrence A. Kohn Senior Teaching Fellow | Outstanding Teaching Contributions, Department of Medicine, Univ 2004 - 2006

Awards & Honors (Local)

Faculty Academic Mentoring Award | University of Rochester School of Medicine and Dentistry | University of Rochester 2012
Scholar in Clinical Research | Leukemia and Lymphoma Society 2008 - 2008
America's Top Doctors Selection 2008 - 2008
Jacob Gitleman Award | Gilda's Club and Cancer Action | Rochester, NY 2007 - 2007
Clinical Investigator Career Development Award | Lymphoma Research Foundation 2003 - 2003
Clinical Oncology Research Fellowship " Immunotherapy of Hodgkin's Disease" | Berlex Oncology Foundation 2001 - 2003
Rising stars program for innovative research | Dunkin Donuts and Dana-Farber Cancer Institute Department of Adu 2001 - 2003

Recent Journal Articles

Showing the 5 most recent journal articles. 116 available »

2016 Oct 1
Dhakal S, Bates JE, Casulo C, Friedberg JW, Becker MW, Liesveld JL, Constine LS. "Patterns and Timing of Failure for Diffuse Large B-Cell Lymphoma After Initial Therapy in a Cohort Who Underwent Autologous Bone Marrow Transplantation for Relapse." International journal of radiation oncology, biology, physics. 2016 Oct 1; 96(2):372-8. Epub 2016 May 27.
2016 Oct
Ban KA, Cohen ME, Ko CY, Friedberg MW, Stulberg JJ, Zhou L, Hall BL, Hoyt DB, Bilimoria KY. "Evaluation of the ProPublica Surgeon Scorecard "Adjusted Complication Rate" Measure Specifications." Annals of surgery. 2016 Oct; 264(4):566-74.
2016 Aug
Nabhan C, Zhou X, Day BM, Dawson K, Zelenetz AD, Friedberg JW, Cerhan JR, Link BK, Flowers CR. "Disease, treatment, and outcome differences between men and women with follicular lymphoma in the United States." American journal of hematology. 2016 Aug; 91(8):770-5. Epub 2016 May 24.
2015 May
Nastoupil LJ, Sinha R, Byrtek M, Ziemiecki R, Taylor M, Friedberg JW, Koff JL, Link BK, Cerhan JR, Dawson KL, Flowers CR. "Comparison of the effectiveness of frontline chemoimmunotherapy regimens for follicular lymphoma used in the United States." Leukemia & lymphoma. 2015 May; 56(5):1295-302. Epub 2014 Nov 05.
2015 Apr 1
Dabaja BS, Vanderplas AM, Crosby-Thompson AL, Abel GA, Czuczman MS, Friedberg JW, Gordon LI, Kaminski M, Niland J, Millenson M, Nademanee AP, Zelenetz A, LaCasce AS, Rodriguez MA. "Radiation for diffuse large B-cell lymphoma in the rituximab era: analysis of the National Comprehensive Cancer Network lymphoma outcomes project." Cancer. 2015 Apr 1; 121(7):1032-9. Epub 2014 Dec 09.

Current Appointments

Director - Cancer Center - Primary Administrative
Samuel E. Durand Chair in Medicine - Department of Medicine (SMD)
Professor - Department of Medicine, Hematology/Oncology (SMD) - Primary


Internal Medicine - American Board of Internal Medicine
Medical Oncology - American Board of Internal Medicine
Hematology - American Board of Internal Medicine


MS | Clinical Investigation | Harvard Medical School2001
MD | Medicine | Harvard Medical School1994
BA | Biology | Williams College1990

Post-Doctoral Training & Residency

Fellowship in Hematology/Oncology at Dana-Farber Cancer Institute07/01/1997 - 06/01/1999
Residency in Internal Medicine at Massachusetts General Hospital07/01/1995 - 06/01/1997
Internship in Internal Medicine at Massachusetts General Hospital07/01/1994 - 06/30/1995